Quinolone Safety and Efficacy. - Wikidata - wikimedia - TriplyDB

Quinolone Safety and Efficacy.

Quinolone Safety and Efficacy.

http://www.wikidata.org/entity/Q45972915

about

Quinolone Safety and Efficacy.

http://www.wikidata.org/entity/Q45972915

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Quinolone Safety and Efficacy.

@en

Quinolone Safety and Efficacy.

@nl

type

label

Quinolone Safety and Efficacy.

@en

Quinolone Safety and Efficacy.

@nl

prefLabel

Quinolone Safety and Efficacy.

@en

Quinolone Safety and Efficacy.

@nl

P1433

Q45972915-2C020B65-5C8D-47A9-BE2C-D9952CE5DF70

P1476

Q45972915-559C6E2D-9563-4775-8E21-5D69497EE7D3

P2093

Q45972915-32EBE0AC-4107-457F-9D77-CB11605A82BF

P2860

Q45972915-000B6C26-B8CF-4240-A6D1-D950D43BF63E

Q45972915-1E2955AD-B2A6-4ECB-9E23-9E034A14AFB9

Q45972915-1E3C4C00-F5B3-41E3-8D45-D8066576000F

Q45972915-5AE63D94-F029-4B4B-8D48-3A57D8E56407

Q45972915-62287192-0A0C-4B33-BFB6-590E32FDBE99

Q45972915-88BF9324-599A-4E22-871C-863371CB0A1D

Q45972915-A8E6F89A-CAF8-4129-AD7A-1489564AC80E

Q45972915-AC288274-7005-4896-B036-3E929BB7FA37

Q45972915-B9072E91-7DBF-45C5-92D8-B51F497A2ABD

Q45972915-DAD7DEE6-1795-45B9-8C88-D312D5CF2B90

P304

Q45972915-4BE14141-5DD8-4670-A7E2-E82DCEF41F95

P31

Q45972915-D4755DFD-4FCA-4C5F-82CE-0D8306443117

P356

Q45972915-0657582B-ADC0-4357-A52C-990F9C5A27BC

P433

Q45972915-3573F140-3D20-4B67-AF27-F7DA7CBE3764

P478

Q45972915-31DD674A-ACB0-45CE-BF6E-8C2DF78A14CC

P577

Q45972915-42B9E2A9-DB5E-40ED-B99A-AEFC1D41F6BD

P921

Q45972915-F4C2CA0C-4958-4CB8-805E-F22E72EC0EFE

P932

Q45972915-F4E4D7C7-D6A6-4FC8-B5B7-9D6CDB65B759

P356

P1433

Emerging Infectious Diseases

P1476

Quinolone Safety and Efficacy

@en

P2093

Spartaco Bellomo

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

Maintaining fluoroquinolone class efficacy: review of influencing factors.

A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia.

Antimicrobial treatment guidelines for acute bacterial rhinosinusitis.

Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome.

Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults.

Quinolone safety and efficacy more important than potency.

Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin.

Pharmacokinetics and pharmacodynamics of intravenous levofloxacin in patients with early-onset ventilator-associated pneumonia.

Effects of fluoroquinolones on insulin secretion and beta-cell ATP-sensitive K+ channels.

P304

985-987

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3201/EID1106.040740

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2005-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P921

P932

3367587

http://www.w3.org/2001/XMLSchema#string